SUPN · ISSUER CIK 1356576
SUPERNUS PHARMACEUTICALS, INC.
Between Aug 1, 2026 and Oct 29, 2026, 5 SUPERNUS PHARMACEUTICALS, INC. insiders reported $0.00 of open-market purchases and $0.00 of sales on SEC Form 4.
↗5 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$0.00Insider buying
$0.00Insider selling
$0.00Net open-market
Aug 14, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 14, 202617:12 | Aug 12, 2026 | SUPN | President, CEO, Director | M · Exercise | — | +29,849 | 1,270,993 | +2% | — | ||
| Aug 14, 202617:12 | Aug 12, 2026 | SUPN | President, CEO, Director | F · Tax | $46.57 | −12,642 | 1,258,351 | -1% | $589K | ||
| Aug 14, 202617:11 | Aug 12, 2026 | SUPN | SVP, Chief Medical Officer | M · Exercise | — | +750 | 14,342 | +6% | — | ||
| Aug 14, 202617:11 | Aug 12, 2026 | SUPN | SVP, Chief Medical Officer | F · Tax | $46.57 | −363 | 13,979 | -3% | $17K | ||
| Aug 14, 202617:11 | Aug 12, 2026 | SUPN | Sr. VP of IP, CSO | M · Exercise | — | +2,500 | 19,795 | +14% | — | ||
| Aug 14, 202617:11 | Aug 12, 2026 | SUPN | Sr. VP of IP, CSO | F · Tax | $46.57 | −1,158 | 18,637 | -6% | $54K | ||
| Aug 14, 202617:10 | Aug 12, 2026 | SUPN | SVP, Chief Tech. Ops. Officer | M · Exercise | — | +1,650 | 20,341 | +9% | — | ||
| Aug 14, 202617:10 | Aug 12, 2026 | SUPN | SVP, Chief Tech. Ops. Officer | F · Tax | $46.57 | −797 | 19,544 | -4% | $37K | ||
| Aug 14, 202617:09 | Aug 12, 2026 | SUPN | Senior Vice-President & CFO | M · Exercise | — | +1,250 | 9,733 | +15% | — | ||
| Aug 14, 202617:09 | Aug 12, 2026 | SUPN | Senior Vice-President & CFO | F · Tax | $46.57 | −604 | 9,129 | -6% | $28K |